Literature DB >> 32003376

Attenuation of benign prostatic hyperplasia by hydrophilic active compounds from pigmented rice in a testosterone implanted rat model.

Ranchana Yeewa1, Wannachai Sakuludomkan1, Chanarat Kiriya2, Chakkrit Khanaree3, Teera Chewonarin1.   

Abstract

Benign prostatic hyperplasia (BPH) is a common chronic disease in aging men. The present study aimed to identify the active fraction of a purple rice extract and determine its anti-prostatic hyperplasia effect in a testosterone implanted rat model. The hexane insoluble fraction (HIF) which mainly contains hydrophilic phytochemicals from the purple rice crude ethanolic extract was defined as the active fraction, due to a potent effect on the downregulation of androgen receptor (AR) expression in malignant prostate cells, in addition to low toxicity for normal fibroblast cells. To induce BPH, subcutaneous implanting of a testosterone containing tube was performed in the castrated rats. Oral administration of HIF of at least 0.1 g kg-1 retarded prostate enlargement and improved histological changes induced by testosterone, without any effects on the serum testosterone levels. A lower proliferating cell nuclear antigen (PCNA) labelling index and the downregulated expression of AR, cyclinD1, and fatty acid synthase were clearly observed in the prostates of HIF-fed rats. Additionally, the mRNA levels of inflammation-related cytokines and enzymes in the prostate tissues significantly decreased after HIF treatment. Taken together, these findings demonstrate molecular mechanisms underlying the potential protective effects of the purple rice active fraction against testosterone-induced BPH in rats.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32003376     DOI: 10.1039/c9fo02820j

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  2 in total

1.  Hexane Insoluble Fraction from Purple Rice Extract Retards Carcinogenesis and Castration-Resistant Cancer Growth of Prostate Through Suppression of Androgen Receptor Mediated Cell Proliferation and Metabolism.

Authors:  Ranchana Yeewa; Aya Naiki-Ito; Taku Naiki; Hiroyuki Kato; Shugo Suzuki; Teera Chewonarin; Satoru Takahashi
Journal:  Nutrients       Date:  2020-02-20       Impact factor: 5.717

2.  Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia.

Authors:  Ramona D'Amico; Tiziana Genovese; Marika Cordaro; Rosalba Siracusa; Enrico Gugliandolo; Alessio Filippo Peritore; Livia Interdonato; Rosalia Crupi; Salvatore Cuzzocrea; Rosanna Di Paola; Roberta Fusco; Daniela Impellizzeri
Journal:  Antioxidants (Basel)       Date:  2021-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.